Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis)
BACKGROUND: Depression in patients with schizophrenia worsens the course of the disease by increasing the risk of suicide, by complicating the clinical picture of the disorder, and by reducing the quality of the social functioning; its treatment is difficult, since monotherapy, even when involving m...
Main Authors: | Aleksandr M. Reznik, Timur S. Syunyakov, Aleksandr V. Mudrak, Nikolay B. Zakharov, Zhanna B. Popova, Anastasia N. Khoroshilova, Ilona G. Khurbatova, Alina M. Saifulina, Anton M. Eliseenko, Tatiana K. Matvievskaya, Angelina N. Khannanova |
---|---|
Format: | Article |
Language: | English |
Published: |
Eco-Vector
2023-03-01
|
Series: | Consortium Psychiatricum |
Subjects: | |
Online Access: | https://consortium-psy.com/jour/article/viewFile/3728/pdf |
Similar Items
-
Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression
by: Alexander M. Reznik, et al.
Published: (2022-09-01) -
Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia
by: Elmars Rancans, et al.
Published: (2022-01-01) -
Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
by: G. Mattingly, et al.
Published: (2021-04-01) -
Efficacy of vortioxetine monotherapy compared with combined therapy vortioxetine and olanzapine in the treatment of major depression – first results
by: Oppa M., et al.
Published: (2017-09-01) -
Clinical case of the use of cariprazine in treatment-resistant simple schizophrenia
by: R. F. Nasyrova
Published: (2022-12-01)